Andros Pharmaceuticals Co., Ltd.’s (6917) Moving Averages Convergence Divergence (MACD) indicator is -0.91, suggesting Andros Pharmaceuticals Co., Ltd. is a Buy.
Andros Pharmaceuticals Co., Ltd.’s (6917) 20-Day exponential moving average is TWD 32.52, while Andros Pharmaceuticals Co., Ltd.’s (6917) share price is TWD 29.80, making it a Sell.
Andros Pharmaceuticals Co., Ltd.’s (6917) 50-Day exponential moving average is TWD 33.20, while Andros Pharmaceuticals Co., Ltd.’s (6917) share price is TWD 29.80, making it a Sell.
Andros Pharmaceuticals Co., Ltd.’s (6917) 10-Day exponential moving average is TWD 31.69, while Andros Pharmaceuticals Co., Ltd.’s (6917) share price is TWD 29.80, making it a Sell.
Andros Pharmaceuticals Co., Ltd.’s (6917) 100-Day exponential moving average is TWD 32.79, while Andros Pharmaceuticals Co., Ltd.’s (6917) share price is TWD 29.80, making it a Sell.
Andros Pharmaceuticals Co., Ltd.’s (6917) stock price is TWD 29.80 and Andros Pharmaceuticals Co., Ltd.’s (6917) 50-day simple moving average is TWD 33.75, creating a Sell signal.
Andros Pharmaceuticals Co., Ltd.’s (6917) stock price is TWD 29.80 and Andros Pharmaceuticals Co., Ltd.’s (6917) 100-day simple moving average is TWD 32.95, creating a Sell signal.
Andros Pharmaceuticals Co., Ltd.’s (6917) stock price is TWD 29.80 and Andros Pharmaceuticals Co., Ltd.’s (6917) 200-day simple moving average is TWD 30.54, creating a Sell signal.